1. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease. (May 2017) Authors: Hanania, Nicola A.; Tashkin, Donald P.; Kerwin, Edward M.; Donohue, James F.; Denenberg, Michael; O'Donnell, Denis E.; Quinn, Dean; Siddiqui, Shahid; Orevillo, Chad; Maes, Andrea; Reisner, Colin Journal: Respiratory medicine Issue: Volume 126(2017) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial. (June 2018) Authors: Kerwin, Edward; Wachtel, Andrew; Sher, Lawrence; Nyberg, Jack; Darken, Patrick; Siddiqui, Shahid; Duncan, Elizabeth A.; Reisner, Colin; Dorinsky, Paul Journal: Respiratory medicine Issue: Volume 139(2018) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Issue 10 (October 2018) Authors: Ferguson, Gary T; Rabe, Klaus F; Martinez, Fernando J; Fabbri, Leonardo M; Wang, Chen; Ichinose, Masakazu; Bourne, Eric; Ballal, Shaila; Darken, Patrick; DeAngelis, Kiernan; Aurivillius, Magnus; Dorinsky, Paul; Reisner, Colin Journal: Lancet Issue: Volume 6:Issue 10(2018) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. What are coroners and pathologists for?. (1st April 2009) Authors: Reisner, Colin Journal: BMJ Issue: Volume 338(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment. (13th June 2022) Authors: Kerwin, Edward; Dorinsky, Paul; Patel, Mehul; Rossman, Kimberly; Reisner, Colin; Maes, Andrea; Darken, Patrick; Griffis, Dianne; Fjällbrant, Harald Journal: Journal of asthma Issue: Volume 59:Number 7(2022) Page Start: 1420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to "A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD" [Resp Med 108 (2014) 1327–1335]. Issue 10 (October 2015) Authors: Quinn, Dean; Seale, J.P.; Reisner, Colin; Fischer, Tracy; Golden, Michael; Fernandez, Carlos; Darken, Patrick; St. Rose, Earl; Thomas, Mervyn; Tardie, Gregory; Orevillo, Chadwick Journal: Respiratory medicine Issue: Volume 109:Issue 10(2015) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD. (November 2016) Authors: Tashkin, Donald P.; Martinez, Fernando J.; Rodriguez-Roisin, Roberto; Fogarty, Charles; Gotfried, Mark; Denenberg, Michael; Gottschlich, Gregory; Donohue, James F.; Orevillo, Chad; Darken, Patrick; St Rose, Earl; Strom, Shannon; Fischer, Tracy; Golden, Michael; Reisner, Colin Journal: Respiratory medicine Issue: Volume 120(2016) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD. (May 2020) Authors: De Backer, Wilfried; De Backer, Jan; Verlinden, Ilse; Leemans, Glenn; Van Holsbeke, Cedric; Mignot, Benjamin; Jenkins, Martin; Griffis, Dianne; Ivanov, Stefan; Fitzpatrick, Jane; St Rose, Earl; Martin, Ubaldo J.; Reisner, Colin Journal: Therapeutic advances in respiratory disease Issue: Volume 14(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD. (November 2016) Authors: Tashkin, Donald P.; Martinez, Fernando J.; Rodriguez-Roisin, Roberto; Fogarty, Charles; Gotfried, Mark; Denenberg, Michael; Gottschlich, Gregory; Donohue, James F.; Orevillo, Chad; Darken, Patrick; St Rose, Earl; Strom, Shannon; Fischer, Tracy; Golden, Michael; Reisner, Colin Journal: Respiratory medicine Issue: Volume 120(2016) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults. (June 2018) Authors: Darken, Patrick; DePetrillo, Paolo; Reisner, Colin; St Rose, Earl; Dorinsky, Paul Journal: Pulmonary pharmacology & therapeutics Issue: Volume 50(2018) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗